T cell dynamics in HIV-1 infection

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 265-304

  Douek, Daniel C ^a   Picker, Louis J ^b   Koup, Richard A ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Activation; Lymphopenia; T cells

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 7;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BONE MARROW; CELL DEATH; CELL POPULATION; CELL RENEWAL; CELLULAR IMMUNITY; DISEASE COURSE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION; INFLAMMATION; LYMPH NODE; LYMPHOCYTOPENIA; LYMPHOID TISSUE; MEMORY CELL; MOLECULAR DYNAMICS; NONHUMAN; PATHOGENESIS; PHYSIOLOGY; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; TARGET CELL; THYMUS; TISSUE DISTRIBUTION; VIRUS REPLICATION; ACUTE DISEASE; ANIMAL; BIOLOGICAL MODEL; CD4+ T LYMPHOCYTE; CHRONIC DISEASE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; MONKEY DISEASE; SIMIAN IMMUNODEFICIENCY VIRUS; VIROLOGY;

ACUTE DISEASE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CELL DEATH; CHRONIC DISEASE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; LYMPHOPENIA; MODELS, IMMUNOLOGICAL; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; T-LYMPHOCYTES; VIRUS REPLICATION;

EID: 0041888480     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141053     Document Type: Review

References (339)

1. + T-cell depletion in HIV disease. Nature 410:974-79
2. Rowland-Jones S. 1999. HIV infection: Where have all the T cells gone? Lancet 354:5-7
3. + T-cell depletion in HIV infection: Are we closer to understanding the cause? Nat. Med. 8:319-23
4. Asquith B, Hanon E, Taylor GP, Bangham CR. 2000. Is human T-cell lymphotropic virus type I really silent? Philos. Trans. R. Soc. London Ser. B 355:1013-19
5. +) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. J. Virol. 76:5082-93
6. Cooper DA, Gold J, MacLean P, Donovan B, Finlayson R, et al. 1985. Acute AIDS retrovirus infection: definition of a clinical illness associated with seroconversion. Lancet 1:537-40
7. Ho DD, Sargadharan MG, Resnick L, DiMarzo-Veronese F, Rota TR, et al. 1985. Primary human T-lymphotropic virus type III infection. Ann. Int. Med. 103:880-83
8. Henrard DR, Daar E, Farzadegan H, Clark SJ, Phillips J, et al. 1995. Virologic and immunologic characterization of symptomatic and asymptomatic primary HIV-1 infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 9:305-10
9. Daar ES, Moudgil T, Meyer RD, Ho DD. 1991. Transient high levels of viremia in patients with primary human immunodeficiency virus type 1 infection. N. Engl. J. Med. 324:961-64
10. Clark SJ, Saag MS, Decker WD, Campbell-Hill S, Roberson JL, et al. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-60
11. Schacker TW, Hughes JP, Shea T, Coombs RW, Corey L. 1998. Biological and virologic characteristics of primary HIV infection. Ann. Intern. Med. 128:613-20
12. Grovit-Ferbas K, Pappas T, O'Brien WA. 1999. Human immunodeficiency virus. In Persistent Viral Infections, ed. R Ahmed, AI Chen, pp. 3-45. Chicester, UK: Wiley
13. Lyles RH, Munoz A, Yamashita TE, Bazmi H, Detels R, et al. 2000. Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J. Infect. Dis. 181:872-80
14. Cohen OJ, Fauci AS, eds. 2001. Pathogenesis and Medical Aspects of HIV-1 Infection, pp. 2043-94. Philadelphia: Lippincott Williams & Wilkins
15. +) T ceils during primary HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:8869-73
16. + T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy. Nat. Med. 5:512-17
17. Finzi D, Hermankova M, Pierson T, Carruth LM, Buck C, et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-300
18. Chun TW, Carruth L, Finzi D, Shen X, DiGiuseppe JA, et al. 1997. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection. Nature 387:183-88
19. Koup RA, Safrit JT, Cao Y, Andrews CA, Wu Y, et al. 1994. Temporal association of cellular immune response with the initial control of viremia in primary HIV-1 syndrome. J. Virol. 68:4650-55
20. + cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency vires type 1 infection. J. Virol. 68:6103-10
21. + T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression. Nat. Med. 5:518-25
22. + T cell responses associated with control of viremia. Science 278:1447-50
23. + T cell demographics and dynamics in lymphatic tissues. Annu. Rev. Immunol. 17:625-56
24. Pantaleo G, Graziosi C, Fauci A. 1993. The immunopathogenesis of human immunodeficiency virus infection. N. Engl. J. Med. 328:327-35
25. Doms RW. 2001. Chemokine receptors and HIV entry. AIDS 15(Suppl. 1):S34-35
26. Schuitemaker H, Koot M, Kootstra NA, Dercksen MW, de Goede RE, et al. 1992. Biological phenotype of human immunodeficiency virus type 1 clones at different stages of infection: progression of disease is associated with a shift from monocytotropic to T-cell-tropic virus population. J. Virol. 66:1354-60
27. +) T cell decline. Proc. Natl. Acad. Sci. USA 97:1269-74
28. Scarlatti G, Tresoldi E, Bjorndal A, Fredriksson R, Colognesi C, et al. 1997. In vivo evolution of HIV-1 co-receptor usage and sensitivity to chemokine-mediated suppression. Nat. Med. 3:1259-65
29. Zhang Y, Lou B, Lal RB, Gettie A, Marx PA, et al. 2000. Use of inhibitors to evaluate coreceptor usage by simian and simian/human immunodeficiency viruses and human immunodeficiency virus type 2 in primary cells. J. Virol. 74:6893-910
30. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-14
31. + cell depletion and progression to AIDS. Ann. Intern. Med. 118:681-88
32. Connor RI, Sheridan KE, Ceradini D, Choe S, Landau NR. 1997. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185:621-28
33. Richman DD, Bozzette SA. 1994. The impact of the syncytium-inducing phenotype of human immunodeficiency virus on disease progression. J. Infect. Dis. 169:968-74
34. Pierson T, Hoffman TL, Blankson J, Finzi D, Chadwick K, et al. 2000. Characterization of chemokine receptor utilization of viruses in the latent reservoir for human immunodeficiency virus type 1. J. Virol. 74:7824-33
35. McChesney M, Sawai ET, Miller CJ. 1999. Simian immunodeficiency virus. In Persistent Viral Infections, ed. R Ahmed, AI Chen, pp. 46-66. Chicester, UK: Wiley
36. Pohlmann S, Soilleux EJ, Baribaud F, Leslie GJ, Morris LS, et al. 2001. DC-SIGNR, a DC-SIGN homologue expressed in endothelial cells, binds to human and simian immunodeficiency viruses and activates infection in trans. Proc. Natl. Acad. Sci. USA 98:2670-75
37. Chen Z, Zhou P, Ho DD, Landau NR, Marx PA. 1997. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J. Virol. 71:2705-14
38. +) T-cell depletion and enteropathy in simian immunodeficiency virus-infected rhesus macaques. Gastroenterology 116:1115-23
39. +) T-cell depletion at all stages of simian immunodeficiency virus infection compared to peripheral lymphocytes. J. Virol. 72:6646-56
40. +) T cells in lymphoid tissues during simian immunodeficiency virus infection. J. Virol. 74:11001-7
41. Vajdy M, Veazey RS, Knight HK, Lackner AA, Neutra MR. 2000. Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques. Am. J. Pathol. 157:485-95
42. + T cell depletion and viral replication in SIV infection. Science 280:427-31
43. +) T cells are rapidly eliminated in early SIV infection in vivo. J. Virol. 74:57-64
44. Stahl-Hennig C, Steinman RM, Tenner-Racz K, Pope M, Stolte N, et al. 1999. Rapid infection of oral mucosal-associated lymphoid tissue with simian immunodeficiency virus. Science 285:1261-65
45. +T cells. Science 286:1353-57
46. Bakri Y, Schiffer C, Zennou V, Charneau P, Kahn E, et al. 2001. The maturation of dendritic cells results in postintegration inhibition of HIV-1 replication. J. Immunol. 166:3780-88
47. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GC, Adema GJ, et al. 2000. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 100:575-85
48. Geijtenbeek TB, Kwon DS, Torensma R, van Vliet SJ, van Duijnhoven GC, et al. 2000. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 100:587-97
49. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. 2002. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 16:135-44
50. Piguet V, Blauvelt A. 2002. Essential roles for dendritic cells in the pathogenesis and potential treatment of HIV disease. J. Invest. Dermatol. 119: 365-69
51. Hu J, Gardner MB, Miller CJ. 2000. Simian immunodeficiency virus rapidly penetrates the cervicovaginal mucosa after intravaginal inoculation and infects intraepithelial dendritic cells. J. Virol. 74:6087-95
52. Reimann KA, Tenner-Racz K, Racz P, Montefiori DC, Yasutomi Y, et al. 1994. Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques. J. Virol. 68:2362-70
53. Schacker T, Little S, Connick E, Gebhard K, Zhang ZQ, et al. 2001. Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection. J. Infect. Dis. 183:555-62
54. Schacker T, Little S, Connick E, Gebhard-Mitchell K, Zhang ZQ, et al. 2000. Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy. J. Infect. Dis. 181:354-57
55. Pantaleo G, Graziosi C, Demarest JF, Butini L, Montroni M, et al. 1993. HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease. Nature 362:355-58
56. Embretson J, Zupancic M, Ribas JL, Burke A, Racz P, et al. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature 362:359-62
57. Haase AT, Henry K, Zupancic M, Sedgewick G, Faust RA, et al. 1996. Quantitative image analysis of HIV-1 infection in lymphoid tissue. Science 274:985-89
58. Fujiwara M, Tsunoda R, Shigeta S, Yokota T, Baba M. 1999. Human follicular dendritic cells remain uninfected and capture human immunodeficiency virus type 1 through CD54-CD11a interaction. J. Virol. 73:3603-7
59. Heath SL, Tew JG, Szakal AK, Burton GE 1995. Follicular dendritic cells and human immunodeficiency virus infectivity. Nature 377:740-44
60. Cheynier R, Henrichwark S, Hadida F, Pelletier E, Oksenhendler E, et al. 1994. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 78:373-87
61. Grossman Z, Feinberg MB, Paul WE. 1998. Multiple modes of cellular activation and virus transmission in HIV infection: a role for chronically and latently infected cells in sustaining viral replication. Proc. Natl. Acad. Sci. USA 95:6314-19
62. Saltini C, Kirby M, Trapnell BC, Tamura N, Crystal RG. 1990. Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung. J. Exp. Med. 171:1123-40
63. Anton PA, Elliott J, Poles MA, McGowan IM, Matud J, et al. 2000. Enhanced levels of functional HIV-1 co-receptors on human mucosal T cells demonstrated using intestinal biopsy tissue. AIDS 14:1761-65
64. Kunkel EJ, Butcher EC. 2002. Chemokines and the tissue-specific migration of lymphocytes. Immunity 16:1-4
65. Kunkel EJ, Boisvert J, Murphy K, Vierra MA, Genovese MC, et al. 2002. Expression of the chemokine receptors CCR4, CCR5, and CXCR3 by human tissue-infiltrating lymphocytes. Am. J. Pathol. 160:347-55
66. Sallusto F, Lenig D, Mackay CR, Lanzavecchia A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-83
67. Meng G, Sellers MT, Mosteller-Barnum M, Rogers TS, Shaw GM, et al. 2000. Lamina propria lymphocytes, not macrophages, express CCR5 and CXCR4 and are the likely target cell for human immunodeficiency virus type 1 in the intestinal mucosa. J. Infect. Dis. 182:785-91
68. Zaitseva M, Lee S, Rabin R, Tiffany H, Farber J, et al. 1998. CXCR4 and CCR5 on human thymocytes: biological function and role in HIV-1 infection. J. Immunol. 161:3103-13
69. Zack JA, Arrigo SJ, Weitsman SR, Go AS, Haislip A, et al. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-22
70. Korin YD, Zack JA. 1998. Progression to the G1b phase of the cell cycle is required for completion of human immunodeficiency virus type 1 reverse transcription in T cells. J. Virol. 72:3161-68
71. Bukrinsky MI, Stanwick TL, Dempsey MP, Stevenson M. 1991. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 254:423-27
72. Luster AD. 1998. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-45
73. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M, et al. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746-54
74. Unutmaz D, Pileri P, Abrignani S. 1994. Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J. Exp. Med. 180:1159-64
75. + T cells using a combination of cytokines. J. Exp. Med. 188:83-91
76. Unutmaz D, KewalRamani VN, Marmon S, Littman DR. 1999. Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes. J. Exp. Med. 189:1735-46
77. Simmons A, Aluvihare V, McMichael A. 2001. Nef triggers a transcriptional program in T cells imitating single-signal T cell activation and inducing HIV virulence mediators. Immunity 14:763-77
78. Wu Y, Marsh JW. 2001. Selective transcription and modulation of resting T cell activity by preintegrated HIV DNA. Science 293:1503-6
79. Demarchi F, Gutierrez MI, Giacca M. 1999. Human immunodeficiency virus type 1 tat protein activates transcription factor NF-kappaB through the cellular interferon-inducible, double-stranded RNA-dependent protein kinase, PKR. J. Virol. 73:7080-86
80. de Noronha CM, Sherman MP, Lin HW, Cavrois MV, Moir RD, et al. 2001. Dynamic disruptions in nuclear envelope architecture and integrity induced by HIV-1 Vpr. Science 294:1105-8
81. Wang L, Mukherjee S, Jia F, Narayan O, Zhao LJ. 1995. Interaction of virion protein Vpr of human immunodeficiency virus type 1 with cellular transcription factor Sp1 and trans-activation of viral long terminal repeat. J. Biol. Chem. 270:25564-69
82. Aiken C, Trono D. 1995. Nef stimulates human immunodeficiency virus type 1 proviral DNA synthesis. J. Virol. 69:5048-56
83. Du Z, Lang SM, Sasseville VG, Lackner AA, Ilyinskii PO, et al. 1995. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell 82:665-74
84. Cicala C, Arthos J, Selig SM, Dennis G Jr, Hosack DA, et al. 2002. HIV envelope induces a cascade of cell signals in non-proliferating target cells that favor virus replication. Proc. Natl. Acad. Sci. USA 99:9380-85
85. Fackler OT, Baur AS. 2002. Live and let die: Nef functions beyond HIV replication. Immunity 16:493-97
86. Guy-Grand D, Vassalli P. 1993. Gut intraepithelial T lymphocytes. Curr. Opin. Immunol. 5:247-52
87. Mowat AM, Viney JL. 1997. The anatomical basis of intestinal immunity. Immunol. Rev. 156:145-66
88. Reinhardt RL, Khoruts A, Merica R, Zell T, Jenkins MK. 2001. Visualizing the generation of memory CD4 T cells in the whole body. Nature 410:101-5
89. Marzo AL, Vezys V, Williams K, Tough DF, Lefrancois L. 2002. Tissue-level regulation of Th1 and Th2 primary and memory CD4 T cells in response to Listeria infection. J. Immunol. 168:4504-10
90. Masopust D, Vezys V, Marzo AL, Lefrancois L. 2001. Preferential localization of effector memory cells in nonlymphoid tissue. Science 291:2413-17
91. Harouse JM, Gettie A, Tan RC, Blanchard J, Cheng-Mayer C. 1999. Distinct pathogenic sequela in rhesus macaques infected with CCR5 or CXCR4 utilizing SHIVs. Science 284:816-19
92. + lymphocytopenia in acute infection of Asian macaques by a vaginally transmissible subtype-C, CCR5-tropic simian/human immunodeficiency virus (SHIV). J. Acquired Immune Defic. Syndr. 30:133-45
93. +) T-cell depletion, and mucosal membrane transmission in macaques. J. Virol. 74:7851-60
94. + T-cell depletion induced by the highly pathogenic simian/human immunodeficiency virus SHIV(DH12R) is systemic and synchronous. J. Virol. 76:379-91
95. + T cell depletion in HIV-1-infected human lymphoid tissue. Proc. Natl. Acad. Sci. USA 96:663-68
96. Grivel JC, Margolis LB. 1999. CCR5- and CXCR4-tropic HIV-1 are equally cytopathic for their T-cell targets in human lymphoid tissue. Nat. Med. 5:344-46
97. Bonyhadi ML, Su L, Auten J, McCune JM, Kaneshima H. 1995. Development of a human thymic organ culture model for the study of HIV pathogenesis. AIDS Res. Hum. Retroviruses 11:1073-80
98. Bonyhadi M, Rabin L, Salimi S, Brown D, Kosek J, et al. 1993. HIV induces thymus depletion in vivo. Nature 363:728-32
99. Aldrovandi GM, Feuer G, Gao L, Jamieson B, Kristeva M, et al. 1993. The SCID-hu mouse as a model for HIV-1 infection. Nature 363:732-36
100. Uittenbogaart CH, Anisman DJ, Jamieson BD, Kitchen S, Schmid I, et al. 1996. Differential tropism of HIV-1 isolates for distinct thymocyte subsets in vitro. AIDS 10:F9-16
101. Su L, Kaneshima H, Bonyhadi M, Salimi S, Kraft D, et al. 1995. HIV-1-induced thymocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2:25-36
102. Stanley SK, McCune JM, Kaneshima H, Justement JS, Sullivan M, et al. 1993. Human immunodeficiency virus infection of the human thymus and disruption of the thymic microenvironment in the SCID-hu mouse. J. Exp. Med. 178:1151-63
103. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, et al. 1984. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J. Immunol. 133:1710-15
104. Bonhoeffer S, Mohri H, Ho D, Perelson AS. 2000. Quantification of cell turnover kinetics using 5-bromo-2′-deoxyuridine. J. Immunol. 164:5049-54
105. Hellerstein MK. 1999. Measurement of T-cell kinetics: recent methodologic advances. Immunol. Today 20:438-41
106. Pitcher CJ, Hagen SI, Walker JM, Lum R, Mitchell BL, et al. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168:29-43
107. Cao J, Park IW, Cooper A, Sodroski J. 1996. Molecular determinants of acute single-cell lysis by human immunodeficiency virus type 1. J. Virol. 70:1340-54
108. Stewart SA, Poon B, Jowett JB, Chen IS. 1997. Human immunodeficiency virus type 1 Vpr induces apoptosis following cell cycle arrest. J. Virol. 71:5579-92
109. Ahsan N, Langhoff E. 1998. Immunopathogenesis of human immunodeficiency virus. Semin. Nephrol. 18:422-35
110. Casella CR, Finkel TH. 1997. Mechanisms of lymphocyte killing by HIV. Curr. Opin. Hematol. 4:24-31
111. + T cells by a Fas-independent mechanism. J. Exp. Med. 187:1113-22
112. McMichael AJ, Rowland-Jones SL. 2001. Cellular immune responses to HIV. Nature 410:980-87
113. + and redistribution of CCR5-CD4 T lymphocytes during primary human immunodeficiency virus type 1 infection. J. Infect. Dis. 183:736-43
114. Clayton F, Snow G, Reka S, Kotler DP. 1997. Selective depletion of rectal lamina propria rather than lymphoid aggregate CD4 lymphocytes in HIV infection. Clin. Exp. Immunol. 107:288-92
115. Lim SG, Condez A, Lee CA, Johnson MA, Elia C, et al. 1993. Loss of mucosal CD4 lymphocytes is an early feature of HIV infection. Clin. Exp. Immunol. 92:448-54
116. Ullrich R, Schmidt W, Zippel T, Schneider T, Zeitz M, et al. 1998. Mucosal HIV infection. Pathobiology 66:145-50
117. Mackay CR, Marston WL, Dudler L. 1990. Naive and memory T cells show distinct pathways of lymphocyte recirculation. J. Exp. Med. 171:801-17
118. Butcher EC, Picker LJ. 1996. Lymphocyte homing and homeostasis. Science 272:60-66
119. Picker L, Treer J, Ferguson-Damell B, Collins P, Buck D, et al. 1993. Control of lymphocyte recirculation in man. J. Immunol. 150:1105-21
120. Grossman Z, Bentwich Z, Herberman RB. 1993. From HIV infection to AIDS: Are the manifestations of effective immune resistance misinterpreted? Clin. Immunol. Immunopathol. 69:123-35
121. Grossman Z, Herberman RB, Vatnik N, Intrator N. 1998. Conservation of total T-cell counts during HIV infection: alternative hypotheses and implications. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17:450-57
122. + lymphocyte population in the blood of SIV-infected macaques is not reflected in lymph nodes. AIDS Res. Hum. Retroviruses 9:639-46
123. +) lymphocytes after HIV antiretroviral therapy reflects redistribution from lymphoid tissues. J. Clin. Invest. 103:1391-98
124. + T cell homeostasis and function in advanced HIV disease. Science 277:112-16
125. Lederman MM, Connick E, Landay A, Kuritzkes DR, Spritzler J, et al. 1998. Immunologic responses associated with 12 weeks of combination antiretroviral therapy consisting of zidovudine, lamivudine, and ritonavir: results of AIDS Clinical Trials Group Protocol 315. J. Infect. Dis. 178:70-79
126. Pakker N, Notermans D, De Boer R, Roos M, De Wolf F, et al. 1998. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat. Med. 4:208-14
127. Cavert W, Notermans D, Staskus K, Wietgrefe S, Zupancic M, et al. 1997. Kinetics of response in lymphoid tissues to antiretroviral therapy of HIV-1 infection. Science 276:960-64
128. Tenner-Racz K, Stellbrink HJ, van Lunzen J, Schneider C, Jacobs JP, et al. 1998. The unenlarged lymph nodes of HIV-1-infected, asymptomatic patients with high CD4 T cell counts are sites for virus replication and CD4 T cell proliferation. The impact of highly active antiretroviral therapy. J. Exp. Med. 187:949-59
129. + T lymphocytes in HIV-1 infection as measured by Ki-67 antigen. J. Exp. Med. 187:1295-303
130. Rosenberg YJ, Anderson AO, Pabst R. 1998. HIV-induced decline in blood CD4/CD8 ratios: viral killing or altered lymphocyte trafficking? Immunol. Today 19:10-17
131. Wang L, Robb CW, Cloyd MW. 1997. HIV induces homing of resting T lymphocytes to lymph nodes. Virology 228:141-52
132. + lymphocytes. J. Acquired Immune Defic. Syndr. 24:352-62
133. Hengel RL, Jones BM, Kennedy MS, Hubbard MR, McDougal JS. 1999. Markers of lymphocyte homing distinguish CD4 T cell subsets that turn over in response to HIV-1 infection in humans. J. Immunol. 163:3539-48
134. Wang L, Chen JJ, Gelman BB, Konig R, Cloyd MW. 1999. A novel mechanism of CD4 lymphocyte depletion involves effects of HIV on resting lymphocytes: induction of lymph node homing and apoptosis upon secondary signaling through homing receptors. J. Immunol. 162:268-76
135. Rosok BI, Bostad L, Voltersvik P, Bjerknes R, Olofsson J, et al. 1996. Reduced CD4 cell counts in blood do not reflect CD4 cell depletion in tonsillar tissue in asymptomatic HIV-1 infection. AIDS 10:F35-38
136. Heitger A, Greinix H, Mannhalter C, Mayerl D, Kern H, et al. 2000. Requirement of residual thymus to restore normal T-cell subsets after human allogeneic bone marrow transplantation. Transplantation 69:2366-73
137. Mackall CL, Bare CV, Granger LA, Sharrow SO, Titus JA, et al. 1996. Thymic-independent T cell regeneration occurs via antigen-driven expansion of peripheral T cells resulting in a repertoire that is limited in diversity and prone to skewing. J. Immunol. 156:4609-16
138. Mackall C, Hakin F, Gress R. 1997. Restoration of T-cell homeostasis after T-cell depletion. Semin. Immunol. 9:339-46
139. Mackall C, Gress R. 1997. Pathways of T-cell regeneration in mice and humans: implications for bone marrow transplantation and immunotherapy. Immunol. Rev. 157:61-72
140. Roux E, Dumont-Girard F, Starobinski M, Siegrist CA, Helg C, et al. 2000. Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity. Blood 96:2299-303
141. Atkinson K, Hansen JA, Storb R, Goehle S, Goldstein G, Thomas ED. 1982. T-cell subpopulations identified by monoclonal antibodies after human marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 59:1292-98
142. Watanabe N, DeRosa SC, Cmelak A, Hoppe R, Herzenberg LA, et al. 1997. Long-term depletion of naive T cells in patients treated for Hodgkin's disease. Blood 90:3662-72
143. Steffens CM, Smith KY, Landay A, Shott S, Truckenbrod A, et al. 2001. T cell receptor excision circle (TREC) content following maximum HIV suppression is equivalent in HIV-infected and HIV-uninfected individuals. AIDS 15:1757-64
144. Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, et al. 2001. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS 15:1749-56
145. Smith KY, Valdez H, Landay A, Spritzler J, Kessler HA, et al. 2000. Thymic size and lymphocyte restoration in patients with human immunodeficiency virus infection after 48 weeks of zidovudine, lamivudine, and ritonavir therapy. J. Infect. Dis. 181:141-47
146. Vigano A, Vella S, Saresella M, Vanzulli A, Bricalli D, et al. 2000. Early immune reconstitution after potent antiretroviral therapy in HIV-infected children correlates with the increase in thymus volume. AIDS 14:251-61
147. Franco JM, Rubio A, Martinez-Moya M, Leal M, Merchante E, et al. 2002. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 99:3702-6
148. Kolte L, Dreves AM, Ersboll AK, Strandberg C, Jeppesen DL, et al. AS. 2002. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. J. Infect. Dis. 185:1578-85
149. Correa R, Munoz-Fernandez A. 2002. Effects of highly active antiretroviral therapy on thymical reconstitution of CD4 T lymphocytes in vertically HIV-infected children. AIDS 16:1181-83
150. Hochberg EP, Chillemi AC, Wu CJ, Neuberg D, Canning C, et al. 2001. Quantitation of T-cell neogenesis in vivo after allogeneic bone marrow transplantation in adults. Blood 98:1116-21
151. Talvensaari K, Clave E, Douay C, Rabian C, Garderet L, et al. 2002. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood 99:1458-64
152. + T lymphocytes in children on highly active antiretroviral therapy. Dutch study group for children with HIV infections. AIDS 12:2155-59
153. + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 89:3700-7
154. Hakim F, Cepeda R, Kaimei S, Mackall C, McAtee N, et al. 1997. Constraints on CD4 recovery postchemotherapy in adults: thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 90:3789-98
155. Steingrimsdottir H, Gruber A, Bjorkholm M, Svensson A, Hansson M. 2000. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications. Haematologica 85:832-38
156. Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, et al. 2000. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 96:754-62
157. Rep MH, van Oosten BW, Roos MT, Ader HJ, Polman CH, et al. 1997. Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans. J. Clin. Invest. 99:2225-31
158. + T cell counts. Arthritis Rheum. 37:834-38
159. Tanchot C, Le Campion A, Martin B, Leaument S, Dautigny N, et al. 2002. Conversion of naive T cells to a memory-like phenotype in lymphopenic hosts is not related to a homeostatic mechanism that fills the peripheral naive T cell pool. J. Immunol. 168:5042-46
160. Ge Q, Hu H, Eisen HN, Chen J. 2002. Different contributions of thymopoiesis and homeostasis-driven proliferation to the reconstitution of naive and memory T cell compartments. Proc. Natl. Acad. Sci. USA 99:2989-94
161. + T cells in lymphopenic hosts. Immunity 11:183-90
162. Murali-Krishna K, Ahmed A. 2000. Naive T cells masquerading as memory T cells. J. Immunol 165:1733-37
163. Goldrath AW, Bogatzki LY, Bevan MJ. 2000. Naive T cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. J. Exp. Med. 192:557-64
164. Cho BK, Rao VP, Ge Q, Eisen FIN, Chen J. 2000. Homeostasis-stimulated proliferation drives naive T cells to differentiate directly into memory T
165. Ferreira C, Barthlott T, Garcia S, Zamoyska R, Stockinger B. 2000. Differential survival of naive CD4 and CD8 T cells. J. Immunol. 165:3689-94
166. Kieper WC, Jameson SC. 1999. Homeostatic expansion and phenotypic conversion of naive T cells in response to self peptide/MHC ligands. Proc. Natl. Acad. Sci. USA 96:13306-11
167. Opferman JT, Ober BT, Ashton-Rickardt PG. 1999. Linear differentiation of cytotoxic effectors into memory T lymphocytes. Science 283:1745-48
168. Jacob J, Baltimore D. 1999. Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399:593-97
169. +) T cell effectors can become memory cells with high efficiency and without further division. Nat. Immunol. 2:705-10
170. + T-cell memory. Nat. Med. 7:913-19
171. Foulds KE, Zenewicz LA, Shedlock DJ, Jiang J, Troy AE, et al. 2002. Cutting edge: CD4 and CD8 T cells are intrinsically different in their proliferative responses. J. Immunol. 168:1528-32
172. Blattman JN, Antia R, Sourdive DJ, Wang X, Kaech SM, et al. Estimating the precursor frequency of naive antigen-specific CD8 T cells. J. Exp. Med. 195:657-64
173. + stability? Nat. Med. 7:892-93
174. Hayashi N, Liu D, Min B, Ben-Sasson SZ, Paul WE. 2002. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells. Proc. Natl. Acad. Sci. USA 99:6187-91
175. +) T cells after infection. Nat. Immunol. 3:619-26
176. Wu C-Y, Kirman JR, Rotte MJ, Davey DF, Perfetto SP, et al. 2002. Distinct lineages of Th1 cells have differential capacity for memory cell generation in vivo. Nat. Immunol. 3:852-58
177. Tham LE, Mescher MF. 2002. The Post-stimulation program of CD4 versus CD8 T cells (death versus activation-induced nonresponsiveness). J. Immunol. 169:1822-28
178. Dai Z, Lakkis FG. 2001. Cutting edge: secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool. J. Immunol. 167:6711-15
179. Hawkes JS, Gibson RA. 2001. Lymphocyte subpopulations in breast-fed and formula-fed infants at six months of age. Adv. Exp. Med. Biol. 501:497-504
180. Huppert FA, Solomou W, O'Connor S, Morgan K, Sussams P, et al. 1998. Aging and lymphocyte subpopulations: whole-blood analysis of immune markers in a large population sample of healthy elderly individuals. Exp. Gerontol. 33:593-600
181. Ogata K, Tamura H, Yokose N, Dan K, Nomura T. 1996. CD4 lymphopenia and risk of infection in immunogerontologically healthy elderly people. Lancet 347:1408
182. Rea IM, Alexander HD, Crockard AD, Morris TC, Rae IM. 1996. CD4 lymphopenia in very elderly people. Lancet 347:328-29
183. Rea IM, Stewart M, Campbell P, Alexander HD, Crockard AD, et al. 1996. Changes in lymphocyte subsets, interleukin 2, and soluble interleukin 2 receptor in old and very old age. Gerontology 42:69-78
184. Belmin J, Ortega MN, Bruhat A, Mercadier A, Valensi P. 1996. CD4 lymphopenia in elderly patients. Lancet 347:911-22
185. Douek DC, McFarland RD, Keiser PH, Gage EA, Massey JM, et al. 1998. Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690-95
186. Haynes BF, Markert ML, Sempowski GD, Patel DD, Hale LP. 2000. The role of the thymus in immune reconstitution in aging, bone marrow transplantation, and HIV-1 infection. Annu. Rev. Immunol. 18:529-60
187. Ascher MS, Sheppard HW. 1988. AIDS as immune system activation: a model for pathogenesis. Clin. Exp. Immunol. 73:165-67
188. Simmonds P, Beatson D, Cuthbert RJ, Watson H, Reynolds B, et al. 1991. Determinants of HIV disease progression: six-year longitudinal study in the Edinburgh haemophilia/HIV cohort. Lancet 338:1159-63
189. Leng Q, Borkow G, Weisman Z, Stein M, Kalinkovich A, et al. 2001. Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection. J. Acquired Immune Defic. Syndr. 27:389-97
190. Roussanov BV, Taylor JM, Giorgi JV. 2000. Calculation and use of an HIV-1 disease progression score. AIDS 14:2715-22
191. Giorgi JV, Hultin LE, McKeating JA, Johnson TD, Owens B, et al. 1999. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J. Infect. Dis. 179:859-70
192. McCune JM, Hanley MB, Cesar D, Halvorsen R, Hoh R, et al. 2000. Factors influencing T-cell turnover in HIV-1-seropositive patients. J. Clin. Invest. 105:R1-8
193. +) T lymphocyte turnover in simian immunodeficiency virus-infected macaques. Proc. Natl. Acad. Sci. USA 95:6388-93
194. Hellerstein M, Hanley MB, Cesar D, Siler S, Papageorgopoulos C, et al. 1999. Directly measured kinetics of circulating T lymphocytes in normal and HIV-1-infected humans. Nat. Med. 5:83-89
195. Mohri H, Bonhoeffer S, Monard S, Perelson AS, Ho DD. 1998. Rapid turnover of T lymphocytes in SIV-infected rhesus macaques. Science 279:1223-27
196. Kovacs JA, Lempicki RA, Sidorov IA, Adelsberger JW, Herpin B, et al. 2001. Identification of dynamically distinct subpopulations of T lymphocytes that are differentially affected by HIV. J. Exp. Med. 194:1731-41
197. Mohri H, Perelson AS, Tung K, Ribeiro RM, Ramratnam B, et al. 2001. Increased turnover of T lymphocytes in HIV-1 infection and its reduction by antiretroviral therapy. J. Exp. Med. 194:1277-87
198. Fleury S, Rizzardi GP, Chapuis A, Tambussi G, Knabenhans C, et al. 2000. Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy. Proc. Natl. Acad. Sci. USA 97:5393-98
199. Hazenberg MD, Stuart JW, Otto SA, Borleffs JC, Boucher CA, et al. 2000. T-cell division in human immunodeficiency virus (HIV)-1 infection is mainly due to immune activation: a longitudinal analysis in patients before and during highly active antiretroviral therapy (HAART). Blood 95:249-55
200. Douek DC, Betts MR, Hill BJ, Little SJ, Lempicki R, et al. 2001. Evidence for increased T cell turnover and decreased thymic output in HIV infection. J. Immunol. 167:6663-68
201. + T cell repopulation of lymphoid tissues after treatment of HIV-1 infection. Proc. Natl. Acad. Sci. USA 95:1154-59
202. Carcelain G, Blanc C, Leibowitch J, Mariot P, Mathez D, et al. 1999. T cell changes after combined nucleoside analogue therapy in HIV primary infection. AIDS 13:1077-81
203. Rizzardi GP, Tambussi G, Bart PA, Chapuis AG, Lazzarin A, et al. 2000. Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count. AIDS 14:2257-63
204. Andersson J, Fehniger TE, Patterson BK, Pottage J, Agnoli M, et al. 1998. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 12:F123-29
205. + T cell kinetics and activation in human immunodeficiency virus-infected patients who remain viremic despite long-term treatment with protease inhibitor-based therapy. J. Infect. Dis. 185:315-23
206. Anderson RW, Ascher MS, Sheppard HW. 1998. Direct HIV cytopathicity cannot account for CD4 decline in AIDS in the presence of homeostasis: a worst-case dynamic analysis. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 17:245-52
207. Harper ME, Marselle LM, Gallo RC, Wong-Staal F. 1986. Detection of lymphocytes expressing human T-lymphotropic virus type III in lymph nodes and peripheral blood from infected individuals by in situ hybridization. Proc. Natl. Acad. Sci. USA 83:772-76
208. Ameisen JC. 1995. From cell activation to cell depletion. The programmed cell death hypothesis of AIDS pathogenesis. Adv. Exp. Med. Biol. 374:139-63
209. + T cells but a high proportion of replication-competent provirus copies in asymptomatic human immunodeficiency virus type 1 infection. J. Virol. 65:2019-23
210. + T cells. Nature 417:95-98
211. Grossman Z, Polis M, Feinberg MB, Levi I, Jankelevich S, et al. 1999. Ongoing HIV dissemination during HAART. Nat. Med. 5:1099-104
212. Sprent J. 1993. Lifespans of naive, memory and effector lymphocytes. Curr. Opin. Immunol. 5:433-38
213. + T-cell activation in HIV infection is antigenic stimulation. J. Acquired Immune Defic. Syndr. 25:203-11
214. Grossman Z, Herberman R. 1997. T-cell homeostasis in HIV infection is neither failing nor blind: Modified cell counts reflect an adaptive response of the host. Nat. Med. 3:486-90
215. Rey-Cuille MA, Berthier JL, Bomsel-Demontoy MC, Chaduc Y, Montagnier L, et al. 1998. Simian immunodeficiency virus replicates to high levels in sooty mangabeys without inducing disease. J. Virol. 72:3872-86
216. Broussard SR, Staprans SI, White R, Whitehead EM, Feinberg MB, et al. 2001. Simian immunodeficiency virus replicates to high levels in naturally infected African green monkeys without inducing immunologic or neurologic disease. J. Virol. 75:2262-75
217. Kaur A, Grant RM, Means RE, McClure H, Feinberg M, et al. 1998. Diverse host responses and outcomes following simian immunodeficiency virus SIVmac239 infection in sooty mangabeys and rhesus macaques. J. Virol. 72:9597-611
218. Kaur A, Barabasz AF, Rosenzweig M, McClure H, Feinberg MB, et al. 2002. Dynamics of T-lymphocyte turnover in sooty mangabeys, a nonpathogenic host of simian immunodeficiency virus infection. Presented at 9th Conf. on Retroviruses and Opportunistic Infections, Chicago
219. Stahmer I, Ordonez C, Popovic M, Mesquita R, Ekman M, et al. 1996. SIV infection of monkey spleen cells including follicular dendritic cells in different stages of disease. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 11:1-9
220. Zhu Y, Gelbard HA, Roshal M, Pursell S, Jamieson BD, et al. 2001. Comparison of cell cycle arrest, transactivation, and apoptosis induced by the simian immunodeficiency virus SIVagm and human immunodeficiency virus type 1 vpr genes. J. Virol. 75:3791-801
221. + T cell depletion is directly linked to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol. 169:3400-6
222. Roederer M, Dubs JG, Anderson MT, Raju PA, Herzenberg LA. 1995. CD8 naive T cell counts decrease progressively in HIV-infected adults. J. Clin. Invest. 95:2061-66
223. De Rossi A, Walker AS, Klein N, De Forni D, King D, et al. 2002. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial. J. Infect. Dis. 186:312-20
224. + T-lymphocyte regeneration after intensive chemotherapy. N. Engl. J. Med. 332:143-49
225. Bolotin E, Annett G, Parkman R, Weinberg K. 1999. Serum levels of IL-7 in bone marrow transplant recipients: relationship to clinical characteristics and lymphocyte count. Bone Marrow Transpl. 23:783-88
226. Fry TJ, Connick E, Falloon J, Lederman MM, Liewehr DJ, et al. 2001. A potential role for interleukin-7 in T-cell homeostasis. Blood 97:2983-90
227. Napolitano LA, Grant RM, Deeks SG, Schmidt D, De Rosa SC, et al. 2001. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nat. Med. 7:73-79
228. Berzins SP, Godfrey DI, Miller JF, Boyd RL. 1999. A central role for thymic emigrants in peripheral T cell homeostasis. Proc. Natl. Acad. Sci. USA 96:9787-91
229. Gabor MJ, Scollay R, Godfrey DI. 1997. Thymic T cell export is not influenced by the peripheral T cell pool. Eur. J. Immunol. 27:2986-93
230. Berzins SP, Boyd RL, Miller JF. 1998. The role of the thymus and recent thymic migrants in the maintenance of the adult peripheral lymphocyte pool. J. Exp. Med. 187:1839-48
231. Douek D, Vescio R, Betts M, Brenchley J, Hill B, et al. 2000. Assessment of thymic output in adults after haematopoietic stem cell transplant and prediction of T cell reconstitution. Lancet 355:1875-81
232. Gaulton G, Scobie J, Rosenzweig M. 1997. HIV-1 and the thymus. AIDS 11:403-14
233. McCune J. 1997. Thymic function in HIV-1 disease. Semin. Immunol. 9:397-404
234. Rosenzweig. M, Clark DP, Gaulton GN. 1993. Selective thymocyte depletion in neonatal HIV-1 thymic infection. AIDS 7:1601-5
235. Schuurman H, Krone W, Broekuizen R, van Baarlen J, van Veen P, et al. 1989. The thymus in acquired immune deficiency syndrome - comparison with other types of immunodeficiency diseases, and presence of components of human immunodeficiency virus type 1. Am. J. Pathol. 134:1329-38
236. Papiernik M, Brossard Y, Mulliez N, Roume J, Brechot C, et al. 1992. Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. Pediatrics 89:297-301
237. Haynes BE Hale LP, Weinhold KJ, Patel DD, Liao HX, et al. 1999. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J. Clin. Invest. 103:453-60
238. Kourtis AP, Ibegbu C, Nahmias AJ, Lee FK, Clark WS, et al. 1996. Early progression of disease in HIV-infected infants with thymus dysfunction. N. Engl. J. Med. 335:1431-36
239. Nahmias AJ, Clark WS, Kourtis AP, Lee FK, Cotsonis G, et al. 1998. Thymic dysfunction and time of infection predict mortality in human immunodeficiency virus-infected infants. CDC Perinatal AIDS Collaborative Transmission Study Group. J. Infect. Dis. 178:680-85
240. Meyers A, Shah A, Cleveland RH, Cranley WR, Wood B, et al. 2001. Thymic size on chest radiograph and rapid disease progression in human immunodeficiency virus 1-infected children. Pediatr. Infect. Dis. J. 20:1112-18
241. Baskin GB, Murphey Corb M, Martin LN, Davison Fairburn B, Hu FS, et al. 1991. Thymus in simian immunodeficiency virus-infected rhesus monkeys. Lab-Invest. 65:400-7
242. Wykrzykowska J, Rosenzweig M, Veazey R, Simon M, Halvorsen K, et al. 1998. Early regeneration of thymic progenitors in rhesus macaques infected with simian immunodeficiency virus. J. Exp. Med. 187:1767-78
243. + (T4) lymphocyte depletion. Proc. Natl. Acad. Sci. USA 87:7727-31
244. Withers-Ward E, Amado R, Koka P, Jamieson B, Kaplan A, et al. 1997. Transient renewal of thymospoiesis in HIV-infected human thymic implants following antiviral therapy. Nat. Med. 3:1102-9
245. Uittenbogaart CH, Anisman DJ, Zack JA, Economides A, Schmid I, et al. 1994. Effects of cytokines on HIV-1 production by thymocytes. Thymus 23:155-75
246. Jamieson BD, Aldrovandi GM, Zack JA. 1996. The SCID-hu mouse: an in-vivo model for HIV-1 pathogenesis and stem cell gene therapy for AIDS. Semin. Immunol. 8:215-21
247. + cell depletion in human immunodeficiency virus type 1-infected SCID-hu mice suggest direct viral killing of thymocytes in vivo. J. Virol. 71:8245-53
248. +) thymocytes: a critical role for tumor necrosis factor and interleukin-7. J. Virol. 73:7533-42
249. Hatzakis A, Touloumi G, Karanicolas R, Karafoulidou A, Mandalaki T, et al. 2000. Effect of recent thymic emigrants on progression of HIV-1 disease. Lancet 355:599-604
250. Poulin JF, Viswanathan MN, Harris JM, Komanduri KV, Wieder E, et al. 1999. Direct evidence for thymic function in adult humans. J. Exp. Med. 190:479-86
251. Poulin JF, Sekaly RP. 1999. Function of the thymus in HIV-infected adults. JAMA 282:219
252. Douek DC, Koup RA, McFarland RD, Sullivan JL, Luzuriaga K. 2000. Effect of HIV on thymic function before and after antiretroviral therapy in children. J. Infect. Dis. 181:1479-82
253. Zhang LQ, Lewin SR, Markowitz M, Lin H-H, Skulsky E, et al. 1999. Measuring recent thymic emigrants in blood of normal persons and HIV-1-infected individuals before and after effective therapy. J. Exp. Med. 190:725-32
254. Ye P, Kirschner DE. 2002. Reevaluation of T cell receptor excision circles as a measure of human recent thymic emigrants. J. Immunol. 168:4968-79
255. Berkowitz RD, Beckerman KP, Schall TJ, McCune JM. 1998. CXCR4 and CCR5 expression delineates targets for HIV-1 disruption of T cell differentiation. J. Immunol. 161:3702-10
256. Kitchen SG, Zack JA. 1997. CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J. Virol. 71:6928-34
257. Correa R, Munoz-Fernandez MA. 2001. Viral phenotype affects the thymic production of new T cells in HIV-1infected children. AIDS 15:1959-63
258. Pedroza-Martins L, Boscardin WJ, Anisman-Posner DJ, Schols D, Bryson YJ, et al. 2002. Impact of cytokines on replication in the thymus of primary human immunodeficiency virus type 1 isolates from infants. J. Virol. 76:6929-43
259. Res P, Spits H. 1999. Developmental stages in the human thymus. Semin. Immunol. 11:39-46
260. Wolf SS, Cohen A. 1992. Expression of cytokines and their receptors by human thymocytes and thymic stromal cells. Immunology 77:362-68
261. Frederick T, Mascola L, Eller A, O'Neil L, Byers B. 1994. Progression of human immunodeficiency virus disease among infants and children infected perinatally with human immunodeficiency virus or through neonatal blood transfusion. Los Angeles County Pediatric AIDS Consortium and the Los Angeles County-University of Southern California Medical Center and the University of Southern California School of Medicine. Pediatr. Infect. Dis. J. 13:1091-97
262. Levy JA. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289
263. Luzuriaga K, Wu H, McManus M, Britto P, Borkowsky W, et al. 1999. Dynamics of human immunodeficiency virus type 1 replication in vertically infected infants. J. Virol. 73:362-67
264. Brooks DG, Kitchen SG, Kitchen CM, Scripture-Adams DD, Zack JA. 2001. Generation of HIV latency during thymopoiesis. Nat. Med. 7:459-64
265. Moses A, Nelson J, Bagby GC Jr. 1998. The influence of human immunodeficiency virus-1 on hematopoiesis. Blood 91:1479-95
266. Huang SS, Barbour JD, Deeks SG, Huang JS, Grant RM, et al. 2000. Reversal of human immunodeficiency virus type 1-associated hematosuppression by effective antiretroviral therapy. Clin. Infect. Dis. 30:504-10
267. Mir N, Costello C, Luckit J, Lindley R. 1989. HIV-disease and bone marrow changes: a study of 60 cases. Eur. J. Haematol. 42:339-43
268. Bagby GC. 1993. Hematopoiesis. In The Molecular Basis of Hematology, ed. G Stamatoyannopoulos. Philadelphia: Saunders
269. + progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br. J. Haematol. 85:20-24
270. + bone marrow cells are infected with HIV in a subset of seropositive individuals. J. Immunol. 149:689-97
271. O'Murchadha MT, Wolf BC, Neiman RS. 1987. The histologic features of hyperplastic lymphadenopathy in AIDS-related complex are nonspecific. Am. J. Surg. Pathol. 11:94-99
272. Biberfeld P, Porwit-Ksiazek A, Bottiger B, Morfeldt-Mansson L, Biberfeld G. 1985. Immunohistopathology of lymph nodes in HTLV-III infected homosexuals with persistent adenopathy or AIDS. Cancer Res. 45:4665s-70
273. Pantaleo G, Graziosi C, Fauci AS. 1993. The role of lymphoid organs in the pathogenesis of HIV infection. Semin. Immunol. 5:157-63
274. Dummer W, Ernst B, LeRoy E, Lee D, Surh C. 2001. Autologous regulation of naive T cell homeostasis within the T cell compartment. J. Immunol. 166:2460-68
275. Kaldjian EP, Gretz JE, Anderson AO, Shi Y, Shaw S. 2001. Spatial and molecular organization of lymph node T cell cortex: a labyrinthine cavity bounded by an epithelium-like monolayer of fibroblastic reticular cells anchored to basement membrane-like extracellular matrix. Int. Immunol. 13:1243-53
276. Picker LJ, Siegelman MH. 1993. Lymphoid tissues and organs. In Fundamental Immunology, ed. WE Paul, pp. 152-61. New York: Raven
277. Gretz JE, Norbury CC, Anderson AO, Proudfoot AE, Shaw S. 2000. Lymphborne chemokines and other low molecular weight molecules reach high endothelial venules via specialized conduits while a functional barrier limits access to the lymphocyte microenvironments in lymph node cortex. J. Exp. Med. 192:1425-40
278. Ploix C, Lo D, Carson MJ. 2001. A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity. J. Immunol. 167:6724-30
279. Poznansky MC, Olszak IT, Foxall R, Evans RH, Luster AD, et al. 2000. Active movement of T cells away from a chemokine. Nat. Med. 6:543-48
280. Rathmell JC, Farkash EA, Gao W, Thompson CB. 2001. IL-7 enhances the survival and maintains the size of naive T cells. J. Immunol. 167:6869-76
281. +) T-cell dynamics in primary cytomegalovirus infection. Transpl. Proc. 33:2313-14
282. Sester M, Sester U, Gartner B, Kubuschok B, Girndt M, Meyerhans A, et al. 2002. Sustained high frequencies of specific CD4 T cells restricted to a single persistent virus. J. Virol. 76:3748-55
283. Fong TL, Di Bisceglie AM, Biswas R, Waggoner JG, Wilson L, et al. 1994. High levels of viral replication during acute hepatitis B infection predict progression to chronicity. J. Med. Virol. 43:155-58
284. Chang KM, Rehermann B, Chisari FV. 1997. Immunopathology of hepatitis C. Springer Semin. Immunopathol. 19:57-68
285. Messele T, Abdulkadir M, Fontanet AL, Petros B, Hamann D, et al. 1999. Reduced naive and increased activated CD4 and CD8 cells in healthy adult Ethiopians compared with their Dutch counterparts. Clin. Exp. Immunol. 115:443-50
286. Kalinkovich A, Weisman Z, Greenberg Z, Nahmias J, Eitan S, et al. 1998. Decreased CD4 and increased CD8 counts with T cell activation is associated with chronic helminth infection. Clin. Exp. Immunol. 114:414-21
287. Steffens CM, Managlia EZ, Landay A, Al-Harthi L. 2002. Interleukin-7-treated naive T cells can be productively infected by T-cell-adapted and primary isolates of human immunodeficiency virus 1. Blood 99:3310-18
288. +) T cells residing within human lymphoid tissues. Immunity 15:671-82
289. Cheynier R, Gratton S, Halloran M, Stahmer I, Letvin NL, et al. 1998. Antigenic stimulation by BCG vaccine as an in vivo driving force for SIV replication and dissemination. Nat. Med. 4:421-27
290. + HIV-specific T cells during progression to AIDS. Blood 99:2505-11
291. +) T cells. Immunity 15:871-82
292. Kimata JT, Kuller L, Anderson DB, Dailey P, Overbaugh J. 1999. Emerging cytopathic and antigenic simian immunodeficiency virus variants influence AIDS progression. Nat. Med. 5:535-41
293. +) T cells are infected in human immunodeficiency virus type 1-infected individuals. J. Virol. 73:6430-35
294. Phillips AN. 1996. Reduction of HIV concentration during acute infection: independence from a specific immune response. Science 271:497-99
295. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, et al. 1999. HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283:1748-52
296. Gao X, Nelson GW, Karacki P, Martin MP, Phair J, et al. 2001. Effect of a single amino acid change in MHC class I molecules on the rate of progression to AIDS. N. Engl. J. Med. 344:1668-75
297. + cell count and rate of progression to AIDS following acute HIV-1 infection. Multicenter AIDS Cohort Study. AIDS 12:2107-13
298. Kaslow RA, Carrington M, Apple R, Park L, Munoz A, et al. 1996. Influence of combinations of human major histocompatibility complex genes on the course of HIV-1 infection. Nat. Med. 2:405-11
299. Migueles SA, Sabbaghian MS, Shupert WL, Bettinotti MP, Marincola FM, et al. 2000. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term non-progressors. Proc. Natl. Acad. Sci. USA 97:2709-14
300. Kuroda MJ, Schmitz JE, Charini WA, Nickerson CE, Lifton MA, et al. 1999. Emergence of CTL coincides with clearance of virus during primary simian immunodeficiency virus infection in rhesus monkeys. J. Immunol. 162:5127-33
301. + lymphocytes. Science 283:857-60
302. +) T cell depletion in simian immunodeficiency virus-infected macaques. J. Exp. Med. 189:991-98
303. +) lymphocytes in control of simian immunodeficiency virus infection and resistance to rechallenge after transient early antiretroviral treatment. J. Virol. 75:10187-99
304. Price DA, Goulder PJ, Klenerman P, Sewell AK, Easterbrook PJ, et al. 1997. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl. Acad. Sci. USA 94:1890-95
305. Evans DT, O'Connor DH, Jing P, Dzuris JL, Sidney J, et al. 1999. Virus-specific cytotoxic T-lymphocyte responses select for amino-acid variation in simian immunodeficiency virus Env and Nef. Nat. Med. 5:1270-76
306. Allen TM, O'Connor DH, Jing P, Dzuris JL, Mothe BR, et al. 2000. Tat-specific cytotoxic T lymphocytes select for SIV escape variants during resolution of primary viraemia. Nature 407:386-90
307. O' Connor DH, Allen TM, Vogel TU, Jing P, DeSouza IP, et al. 2002. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med. 8:493-99
308. Betts MR, Ambrozak DA, Douek DC, Bonhoeffer SE, Brenchley JM, et al. 2001. Analysis of total human immunodeficiency virus (HIV)-specific CD4 and CD8 T-cell responses: relationship to viral load in untreated HIV infection. J. Virol. 75:11983-91
309. + T cells in HIV-infected progressors and long-term non-progressors. J. Immunol. 165:1082-92
310. +) responses in HIV type 1-infected patients: comparison with anti-Epstein-Barr virus responses and changes during antiretroviral therapy. J. Virol. 73:7108-16
311. + T lymphocytes. Proc. Natl. Acad. Sci. USA 97:3382-87
312. + T cell proliferation. Proc. Natl. Acad. Sci. USA 98:13878-83
313. Ogg GS, Jin X, Bonhoeffer S, Dunbar PR, Nowak MA, et al. 1998. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science 279:2103-6
314. Yu XG, Cohen D, Eldridge R, Johnston MN, Blackard JT, et al. 2002. Whole genome analysis of HIV-1 specific cytotoxic T lymphocyte (CTL) responses on single epitope level in different groups of HIV-1 infected individuals. Presented at 14th Int. AIDS Conf., Barcelona
315. +) T-cell responses following acute HIV-1 infection. J. Virol. 76:8690-701
316. Blancou P, Chenciner N, Cumont MC, Wain-Hobson S, Hurtrel B, et al. 2001. The infiltration kinetics of simian immunodeficiency virus-specific T cells drawn to sites of high antigenic stimulation determines local in vivo viral escape. Proc. Natl. Acad. Sci. USA 98:13237-42
317. Altfeld M, Rosenberg ES, Shankarappa R, Mukherjee JS, Hecht FM, et al. 2001. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J. Exp. Med. 193:169-80
318. Whittle HC, Dossetor J, Oduloju A, Bryceson AD, Greenwood BM. 1978. Cell-mediated immunity during natural measles infection. J. Clin. Invest. 62:678-84
319. Boni C, Bertoletti A, Penna A, Cavalli A, Pilli M, et al. 1998. Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J. Clin. Invest. 102:968-75
320. Carney WP, Hirsch MS. 1981. Mechanisms of immunosuppression in cytomegalovirus mononucleosis. II. Virus-monocyte interactions. J. Infect. Dis. 144:47-54
321. Carney WP, Lacoviello V, Hirsh HS. 1983. Functional properties of T lymphocytes and their subsets in cytomegalovirus mononucleosis. J. Immunol. 130:390-3
322. +) T- cell response in acute hepatitis C. Gastroenterology 117:933-41
323. Mathew A, Kurane I, Green S, Vaughn DW, Kalayanarooj S, et al. 1999. Impaired T cell proliferation in acute dengue infection. J. Immunol. 162:5609-15
324. +) response to hepatitis C and severity of recurrence after liver transplantation. Gastroenterology 117:926-32
325. +) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192:63-75
326. + T cell responses. J. Immunol. 165:6133-41
327. Trimble LA, Shankar P, Patterson M, Daily JP, Lieberman J. 2000. Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3zeta and CD28, key signaling molecules for T- cell activation. J. Virol. 74:7320-30
328. Gamberg JC, Bowmer MI, Trahey JC, Campbell CM, Pardoe I, et al. 1999. Functional and genetic integrity of the CD8 T-cell repertoire in advanced HIV infection. AIDS 13:2043-53
329. Champagne P, Ogg GS, King AS, Knabenhans C, Ellefsen K, et al. 2001. Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 410:106-11
330. Appay V, Papagno L, Spina CA, Hansasuta P, King A, et al. 2002. Dynamics of T cell responses in HIV infection. J. Immunol. 168:3660-66
331. + T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8:379-85
332. +) T cells in healthy and immunosuppressed virus carriers. Blood 98:754-61
333. + T cell subsets during acute Epstein-Barr and human immunodeficiency virus infections in humans. J. Infect. Dis. 182:451-58
334. Gamadia LE, ten Berge IJ, Picker LJ, van Lier RA. 2002. Skewed maturation of virus-specific CTLs? Nat. Immunol. 3:203
335. + T lymphocytes are enriched in antigen-specific T cells capable of down-modulating cytotoxic activity. Int. Immunol. 10:311-23
336. +) T cells in patients with rheumatoid arthritis. Arthritis Rheum. 40:237-48
337. + T cells with restricted T-cell receptor beta chain variability after bone marrow transplantation. Blood 83:587-95
338. Klenerman P, Zinkernagel RM. 1998. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 394:482-85
339. Brenchley JM, Karandikar NJ, Betts MR, Ambrozak DA, Hill BJ, Crotty LE, Casazza J, Kuruppu J, Migueles SA, Connors M, Roederer M, Douek DC, Koup RA. 2003. Expression of CD57 defines replicative senescence and antigen-induced apoptotic death of CD8+ T-cells. Blood In press